To send content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about sending content to .
To send content items to your Kindle, first ensure email@example.com
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about sending to your Kindle.
Note you can select to send to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
Written by practising physicians specializing in pediatric hematology, neonatology, immunology, pediatric infectious disease and transfusion medicine, this is a practical guide to the pathogenesis, recognition and management of hematologic problems in the neonate. The focus is on clinical issues encountered by pediatric specialists, and there are chapters devoted to disorders of leukocytes, platelets, procoagulant and anticoagulant proteins, and disorders of red blood cells. Neonatal transfusion, malignant disorders in the newborn, neonatal hemoglobinopathy screening, harvesting and storage of umbilical cord stem cells are also covered, and practical approaches to diagnosis and treatment given.
It is an honor to be invited to write a foreword to this book. I know my friend and late colleague Dr Frank A. Oski, with whom I coauthored three editions of the monograph Hematology of the Newborn from 1966 to 1982, would echo this sentiment. And he would be delighted that his former fellows Drs Werner and de Alarcón shared our interest in the importance of this subject sufficiently to bring it up to date in an expanded textbook rich with information of great scientific and practical value.
As expected, there have been many important advances in the field of neonatal hematology in the past 20 years – new diseases, new ways of diagnosing, treating, and preventing old diseases. These are covered thoroughly in the chapters written by the authors of this book, each chosen carefully by the editors for his or her expert knowledge and experience.
With progress, diseases that virtually established neonatal hematology as a distinct discipline have largely come under control, reducing the space needs for describing them. There is no greater example of this than in the section devoted here to hemolytic disease of the fetus and newborn (formerly referred to as erythroblastosis fetalis), one that represented the largest chapter in our earlier monograph. All this resulted from the successful implementation in 1968 of Rh immunoglobulin to prevent Rh alloimmunization and hemolytic disease of the newborn.